Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Janus submits filing for shingles drug trials
JA-001 (sorivudine, also known as ARYS-01 cream) has previously demonstrated activity against the varicella zoster virus in both preclinical and clinical studies. Janus plans to conduct clinical studies
JA-001 (sorivudine, also known as ARYS-01 cream) has previously demonstrated activity against the varicella zoster virus in both preclinical and clinical studies. Janus plans to conduct clinical studies
In the studies, mice treated with second-generation investigational immune regulating hormone (IRH) compounds showed increased survival and dramatically reduced inflammation compared to placebo treated animals. Benefit was achieved
The investigational new drug (IND) filing seeks to evaluate LGD2941 as a potential new therapy for the treatment of osteoporosis and frailty. LGD2941 is a selective androgen receptor
Under the terms of the new agreement, Genentech has committed to pay Curis an up-front license fee of $3 million and up to an additional $6 million over
The complaints, launched in 2001 and 2003, alleged that Biovail’s listing with the FDA of a patent for Tiazac (diltiazem) improperly delayed the entry of a competing generic
Virus types to be screened as part of the collaboration potentially include herpes viruses, respiratory viruses, pox viruses, hepatitis B and C, papillomavirus and viruses of biodefense concern
Acorda acquired Zanaflex Capsules and Zanaflex (tizanidine hydrochloride) tablets from the recently troubled Elan Corporation in July 2004. Elan will manufacture Zanaflex Capsules for Acorda at its Athlone,
The study will be conducted by International Oncology Network (ION), the US’s largest network of community-based oncologists, and will include 20 ION sites. The open-label, non-randomized study will
Under the terms of the new agreement, Nuvelo will receive a $2 million upfront payment from Kirin for NU206 with Nuvelo leading worldwide development, manufacturing and commercialization. All
The case was filed in July 2002 by AIDS Healthcare Foundation (AHF), the largest AIDS organization in the US. The legal action challenges the legitimacy of GSK’s claims